Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in adjuvants

J J Donnelly1

  • 1Department of Virus and Cell Biology, Merck Research Laboratories, West Point, PA 19486, USA. john_donnelly@merck.com

Mechanisms of Ageing and Development
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA vaccines.

Methods in molecular medicine·2011
Same author

A Modified ELISA for Measurement of High-Avidity IgG Antibodies to Meningococcal Serogroup C Polysaccharide that Correlate with Bactericidal Titers.

Methods in molecular medicine·2011
Same author

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.

Gene therapy·2001
Same author

Antigen presentation and DNA vaccines.

American journal of respiratory and critical care medicine·2000
Same author

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.

Journal of immunology (Baltimore, Md. : 1950)·2000
Same author

Effect of individual conjugate dose on immunogenicity of type 6B pneumococcal polysaccharide-N. meningitidis outer membrane protein complex conjugate vaccines in infant rhesus monkeys.

Vaccine·2000
Same journal

Human sex-specific hormone effects on cerebrovascular health in males and females.

Mechanisms of ageing and development·2026
Same journal

HTZ-1/H2A.Z expression sustains transcriptional programs that regulate Caenorhabditis elegans lifespan.

Mechanisms of ageing and development·2026
Same journal

PCSK9 promotes aging-related cardiac calcification by inducing osteogenic differentiation of cardiac fibroblasts.

Mechanisms of ageing and development·2026
Same journal

Distinct post-infectious TLR2 immune remodeling in COVID-19-recovered centenarians.

Mechanisms of ageing and development·2026
Same journal

Senescence-associated tertiary lymphoid structures in Sjögren's disease model nishiura mice.

Mechanisms of ageing and development·2026
Same journal

Aging-driven reprogramming of CD34⁺ hematopoietic stem cells in leukemogenesis: Mechanisms and therapeutic implications.

Mechanisms of ageing and development·2026
See all related articles

Researchers are exploring novel vaccine adjuvants to enhance immune responses against specific pathogens. This review highlights advancements and challenges in developing new adjuvants for improved vaccine efficacy and specificity.

Area of Science:

  • Vaccinology and Immunology
  • Biotechnology and Pharmaceutical Sciences

Background:

  • Shift towards purified subunit vaccines over live or inactivated organisms.
  • Increased understanding of immune mechanisms driving targeted vaccine design.
  • Need for novel adjuvants with specific properties for diverse diseases.

Purpose of the Study:

  • Summarize proceedings from a mini-symposium on new adjuvants.
  • Illustrate the potential of novel adjuvants for enhanced vaccine efficacy and specificity.
  • Discuss the complexities of translating adjuvant discoveries from research to clinical application.

Main Methods:

  • Review of recent advancements in adjuvant development.
  • Analysis of immune mechanisms relevant to adjuvant function.
  • Discussion of challenges in clinical translation of new adjuvants.

Related Experiment Videos

Main Results:

  • Identification of promising novel adjuvants with specific properties.
  • Demonstration of potential for improved vaccine efficacy and specificity.
  • Highlighting the translational gap between laboratory discovery and clinical application.

Conclusions:

  • Novel adjuvants offer significant potential for next-generation vaccines.
  • Further research is needed to optimize adjuvant properties for specific diseases.
  • Overcoming clinical translation challenges is crucial for realizing adjuvant potential.